文献速递淋巴瘤白血病

EBV阳性结内T/NK细胞淋巴瘤与克隆性造血及病毒基因组结构变异相关

EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome.
PubMed 文献 · Blood Adv · 2024-01-01

对22例EBV阳性结内T/NK细胞淋巴瘤行全外显子组和/或全基因组测序,发现TET2(68%)和DNMT3A(32%)突变最常见且与总生存差相关(P = .004),EBV基因组结构变异频繁(63%)以缺失为主,1例中PD-L1基因并入EBV基因组致高表达。

要点

  • EBV阳性结内T/NK细胞淋巴瘤中TET2突变占68%、DNMT3A突变占32%,与总生存差相关(P = .004)。
  • 4例可获取骨髓或脾脏配对正常样本中3例存在至少1个相同TET2/DNMT3A突变,提示克隆性造血。
  • EBV基因组结构变异见于63%病例,以缺失为主;1例PD-L1基因并入病毒基因组致蛋白高表达。

核心结论

  • EBV阳性结内T/NK细胞淋巴瘤中频繁的TET2和DNMT3A突变似乎与克隆性造血密切相关,并可能与EBV基因组缺失共同参与这一难治性淋巴瘤的发病。

研究设计与样本

  • 对22例EBV阳性结内T/NK细胞淋巴瘤病例进行全外显子组和/或全基因组测序。

主要发现

  • TET2突变见于68%病例,DNMT3A突变见于32%病例,二者存在与总生存差相关(P = .004)。
  • 2例携带TET2和/或DNMT3A突变的患者中检出RHOA p.Gly17Val突变。
  • 4例存在TET2/DNMT3A改变且可获取骨髓或脾脏作为配对正常样本的患者中,3例在骨髓或脾脏中检出至少1个相同的TET2/DNMT3A突变。
  • EBV基因组结构变异频繁,见于63%的EBV基因组,最常见类型为缺失。
  • 1例患者中4个人类9号染色体片段(包括程序性死亡配体1基因PD-L1)串联整合入EBV基因组,PD-L1的3'非翻译区被截短,导致PD-L1蛋白高水平表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epstein-Barr virus (EBV)-positive (EBV+) nodal T- and natural killer (NK)-cell lymphoma is a peripheral T-cell lymphoma (EBV+ nPTCL) that presents as a primary nodal disease with T-cell phenotype and EBV-harboring tumor cells. To date, the genetic aspect of EBV+ nPTCL has not been fully investigated. In this study, whole-exome and/or whole-genome sequencing was performed on 22 cases of EBV+ nPTCL. TET2 (68%) and DNMT3A (32%) were observed to be the most frequently mutated genes whose presence was associated with poor overall survival (P = .004). The RHOA p.Gly17Val mutation was identified in 2 patients who had TET2 and/or DNMT3A mutations. In 4 patients with TET2/DNMT3A alterations, blood cell-rich tissues (the bone marrow [BM] or spleen) were available as paired normal samples. Of 4 cases, 3 had at least 1 identical TET2/DNMT3A mutation in the BM or spleen. Additionally, the whole part of the EBV genome was sequenced and structural variations (SVs) were found frequent among the EBV genomes (63%). The most frequently identified type of SV was deletion. In 1 patient, 4 pieces of human chromosome 9, including programmed death-ligand 1 gene (PD-L1) were identified to be tandemly incorporated into the EBV genome. The 3' untranslated region of PD-L1 was truncated, causing a high-level of PD-L1 protein expression. Overall, the frequent TET2 and DNMT3A mutations in EBV+ nPTCL seem to be closely associated with clonal hematopoiesis and, together with the EBV genome deletions, may contribute to the pathogenesis of this intractable lymphoma.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kato S, Hamada M, Okamoto A, et al. EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. Blood Adv. 2024. PMID: 38429084. doi:10.1182/bloodadvances.2023012019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。